牛ヘルスケアの市場規模、シェア、成長分析、製品タイプ別、動物タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

牛ヘルスケアの世界市場規模は2023年に85億4,000万米ドルと評価され、2024年の89億8,000万米ドルから2032年には133億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.09％で成長する見通しです。

世界の牛ヘルスケア市場は、人口拡大と所得増加による動物性タンパク質需要の急増に後押しされ、大きな成長を遂げています。消費者が高品質の肉や乳製品を優先する中、家畜生産者は牛群の健康と生産性を維持するために効果的なヘルスケアソリューションを採用する傾向が強まっています。人獣共通感染症の増加により、動物の福祉と食の安全の両方を確保するために、予防接種の実施と定期的な健康モニタリングが必要となっています。さらに、ウェアラブルセンサー、遠隔医療、データ分析などの技術的進歩が牛群管理に革命をもたらし、個別化治療とコスト効率の改善を可能にしています。同時に、倫理的に調達された製品を求める消費者の需要に後押しされ、持続可能な農業の推進が勢いを増しています。しかし、高い獣医療費、低所得地域での不十分なアクセス、規制上のハードルといった課題が、市場の成長を妨げています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 市場に影響を与える要因
• 規制分析
• バリューチェーン分析
• ケーススタディ分析
• 市場の魅力指数（2024年）
• トップ投資ポケット
• 市場エコシステム
• PESTEL分析
• マクロ経済指標
• 価格分析

牛ヘルスケア市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• ワクチン
• 医薬品
  • 鎮痛剤
  • 抗炎症
  • 抗感染
  • 寄生虫駆除剤
  • その他
• 飼料添加物
  • 薬用
  • 栄養

牛ヘルスケア市場規模：動物タイプ別& CAGR（2025-2032）

• 市場概要
• 生産動物
• コンパニオンアニマル

牛ヘルスケア市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 酪農場
• 動物病院
• その他

牛ヘルスケア市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Qiagen
• Boehringer Ingelheim
• Thermo Fisher Scientific
• Elanco Animal Health
• Idexx Laboratories
• IDVet
• Kyoritsuseiyaku Corporation
• Merck & Co Inc.
• Norbrook Laboratories
• Vetoquinol
• Virbac
• Zoetis Inc.
• MSD Animal Health
• Dechra Pharmaceuticals
• Neogen Corporation
• Phibro Animal Health
• Ceva Sante Animale
• Eco Animal Health
• Orion Corporation
• Animalcare Group

結論と提言

Global cattle healthcare Market size was valued at USD 8.54 Billion in 2023 and is poised to grow from USD 8.98 Billion in 2024 to USD 13.36 Billion by 2032, growing at a CAGR of 5.09% during the forecast period (2025-2032).

The global cattle healthcare market is experiencing significant growth, propelled by surging demand for animal protein due to population expansion and rising incomes. As consumers prioritize high-quality meat and dairy products, livestock producers are increasingly adopting effective healthcare solutions to maintain herd health and productivity. Rising zoonotic diseases necessitate the implementation of vaccinations and regular health monitoring to ensure both animal welfare and food safety. Furthermore, technological advancements like wearable sensors, telemedicine, and data analytics are revolutionizing herd management, enabling personalized treatment and improving cost-efficiency. Concurrently, the push for sustainable agriculture is gaining momentum, driven by consumer demand for ethically sourced products. However, challenges such as high veterinary costs, inadequate access in low-income regions, and regulatory hurdles impede market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global cattle healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global cattle healthcare Market Segments Analysis

The global cattle healthcare market is segmented on the basis of product type, end user, and region. By product type, the market is segmented into vaccines, pharmaceuticals (analgesics, anti-inflammatory, anti-infective, parasiticides, and others), and feed additives (medicinal, and nutritional). Based on end user, the market is segmented into dairy farms, veterinary hospitals, and others. On the basis of animal type, the market is segmented into production animal and companion animal. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global cattle healthcare Market

The global cattle healthcare market is being significantly driven by innovative technologies such as precision livestock farming (PLF), wearable biosensors, and artificial intelligence-based health monitoring systems. These advancements facilitate early disease detection, continuous monitoring of vital signs, and optimized feeding and breeding practices, thereby improving herd health and productivity. Furthermore, integrating telemedicine with digital record systems enhances veterinary access and streamlines decision-making processes. Additionally, advancements in vaccine development, genetic screening, and drug delivery methods ensure more effective and efficient cattle treatment. Collectively, these technological improvements reduce animal mortality and illness while boosting the efficiency of cattle farming, subsequently increasing the demand for next-generation veterinary solutions worldwide.

Restraints in the Global cattle healthcare Market

The global cattle healthcare market faces significant restraints primarily due to inadequate infrastructure. This includes a lack of veterinary clinics, cold chain storage for vaccines, and reliable transportation methods, which severely hampers the delivery of veterinary services in remote and underserved regions. Many rural communities, particularly in Africa, struggle with challenging logistics that prevent access to essential veterinary supplies, diagnostics, and professional care. Moreover, the deficiency in infrastructure complicates emergency response efforts during disease outbreaks. Furthermore, poor internet connectivity hinders the implementation of advanced monitoring systems and telemedicine, ultimately restricting the adoption of modern cattle healthcare solutions and stifling market growth.

Market Trends of the Global cattle healthcare Market

The global cattle healthcare market is witnessing a significant shift towards preventive measures, driven by growing awareness among farmers about the economic impacts of livestock diseases. With the rising incidences of conditions such as Bovine Respiratory Disease, stakeholders are increasingly investing in vaccination programs and nutrition-based immunity enhancers to bolster cattle health proactively. Companies like Zoetis report a surge in demand for their preventive vaccine portfolios, reflecting a broader trend of prioritizing preventive over reactive treatments. This strategic shift is not only safeguarding herd health but also enhancing profitability and sustainability in cattle farming worldwide, indicating a robust market evolution.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Regulatory Analysis
• Value Chain Analysis
• Case Study Analysis
• Market Attractiveness Index, 2024
• Top Investment Pocket
• Market Ecosystem
• Pestel Analysis
• Macroeconomic Indicators
• Pricing Analysis

Global Cattle Healthcare Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Vaccines
• Pharmaceuticals
  • Analgesics
  • Anti-Inflammatory
  • Anti-Infective
  • Parasiticides
  • Others
• Feed Additives
  • Medicinal
  • Nutritional

Global Cattle Healthcare Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Production Animal
• Companion Animal

Global Cattle Healthcare Market Size by End User & CAGR (2025-2032)

• Market Overview
• Dairy Farms
• Veterinary Hospitals
• Others

Global Cattle Healthcare Market Size by Region & CAGR (2025-2032)

• North America (Product Type, Animal Type, End User)
  • US
  • Canada
• Europe (Product Type, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, End User)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Idexx Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDVet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsuseiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orion Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animalcare Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations